ENVUE MEDICAL INC NEW
FEED
FEED was delisted on the 15th of September, 2026.
15 hedge funds and large institutions have $2.58M invested in ENVUE MEDICAL INC NEW in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 7 closing their positions.
170% more capital invested
Capital invested by funds: $954K → $2.58M (+$1.62M)
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
29% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 7
15% more funds holding
Funds holding: 13 → 15 (+2)
0.53% more ownership
Funds ownership: 4.66% → 5.19% (+0.53%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
+$319K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$160K |
| 3 |
State Street
Boston,
Massachusetts
|
+$106K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$53.2K |
| 5 |
Bank of New York Mellon
New York
|
+$53.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$106K |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
-$79K |
| 3 |
Renaissance Technologies
New York
|
-$73K |
| 4 |
VF
Virtu Financial
New York
|
-$55K |
| 5 |
PFA
Plotkin Financial Advisors
Chevy Chase,
Maryland
|
-$24.1K |
FEED Hedge Fund Activity: Q3 2021 in Review
15 of the 5,729 institutional investors tracked by Wall St. Rank reported a position in ENVUE MEDICAL INC NEW (FEED) for Q3 2021, worth a combined $2.58M — up 170% from $954K a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new FEED positions and 7 closed out — a net gain of 2 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Two Sigma Investments, opening a new position worth an estimated $319K. The largest seller was Citadel Advisors, cutting an estimated $106K.
- 15 institutional investors held ENVUE MEDICAL INC NEW (FEED) as of Q3 2021, up from 13 in Q2 2021.
- Funds reported $2.58M of ENVUE MEDICAL INC NEW stock for Q3 2021, up 170% quarter-over-quarter.
- 9 funds opened new ENVUE MEDICAL INC NEW positions in Q3 2021 and 7 closed out, a net change of +2 holders.
- The largest ENVUE MEDICAL INC NEW buyer in Q3 2021 was Two Sigma Investments, an estimated $319K added.
- The largest ENVUE MEDICAL INC NEW seller in Q3 2021 was Citadel Advisors, an estimated $106K sold.
Based on aggregated 13F filings for Q3 2021.